Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Sanofi Pasteur MSD welcomes Swiss decision to reimburse vaccination

Sanofi Pasteur MSD welcomes Swiss decision to reimburse vaccination

23rd November 2007

Sanofi Pasteur Merck Sharp and Dohme (MSD) has welcomed the decision by the government of Switzerland to reimburse the human papillomavirus (HPV) vaccination for adolescent girls and young women.

Starting in January 2008, women will be able to protect themselves against cervical cancer and other HPV-related genital diseases through local vaccination programmes.

The Swiss authorities have stated that the vaccination programme will be covered by the state’s mandatory health insurance for 11 to14 year-old girls and through catch-up vaccination programmes for adolescents and young women 15 to 19 years old.

Didier Hoch, president of Sanofi Pasteur MSD, described the decision as “great news” for Switzerland.

He added: “We hope that local vaccination programmes will be generalised quickly throughout Switzerland, so girls and young women could soon have full access to these programmes that will help save lives and prevent other human papillomavirus-related genital diseases.”

Sanofi Pasteur MSD’s Gardasil is the only HPV vaccine currently available in Switzerland.

Earlier this month, MSD released new data on Gardasil which shows that it reduces incidence of HPV 6,11,16 and 18-related persistent infection and disease in women through age 45.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.